Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Matea Cedilak"'
Autor:
Michael Hafner, Susanne Paukner, Wolfgang W Wicha, Boška Hrvačić, Matea Cedilak, Ivan Faraho, Steven P Gelone
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0237659 (2021)
Several antibiotics demonstrate both antibacterial and anti-inflammatory/immunomodulatory activities and are used to treat inflammatory pulmonary disorders. Lefamulin is a pleuromutilin antibiotic approved to treat community-acquired bacterial pneumo
Externí odkaz:
https://doaj.org/article/136f83670bc14055ac4e6c2288b6710a
Autor:
Martina Bosnar, Daniela Belamarić, Matea Cedilak, Lidija Pribolsan, Vedrana Radovanović, Vesna Eraković Haber, Mihailo Banjanac
Publikováno v:
Airway pharmacology and treatment.
Autor:
Matea Cedilak, Ivan Faraho, Mihailo Banjanac, Vesna Eraković Haber, Daniela Belamarić, Martina Bosnar, Ines Glojnarić
Publikováno v:
Mechanisms of lung injury and repair.
Introduction: Precision cut lung slices (PCLS) have mostly been used in toxicity and airway contractility studies due to preserved matrix structure, interaction of multiple cell types and size uniformity, while it’s potential for use in disease pat
Autor:
Martina Bosnar, Ivana Šagud, Irena Škorić, Ana Ratković, Vanja Kelava, Ivo Zlatar, Matea Cedilak
Publikováno v:
Croatica Chemica Acta
Volume 92
Issue 2
Volume 92
Issue 2
Biological activity of naphthoxazoles, fused hetero-benzoxazoles and benzobicyclo[3.2.1]-derivatives was investigated in proliferation and inflammation based assays. The tested compounds were prepared by photocylization or photocycloaddition reaction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f55bef71745e8b5cc495399c645408
https://doi.org/10.5562/cca3530
https://doi.org/10.5562/cca3530
Autor:
Snježana Čužić, Mihailo Banjanac, Vesna Eraković Haber, Ivan Faraho, Matea Cedilak, Krunoslav Ilić, Martina Bosnar, Daniela Belamarić, Andrea Paravić Radičević, Ines Glojnarić
Publikováno v:
Pulmonary pharmacologytherapeutics. 55
Idiopathic pulmonary fibrosis (IPF) is a complex lung disease with incompletely understood pathophysiology . Effectiveness of available medicines is limited and the need for new and improved therapies remains. Due to complexity of the disease, it is